vimarsana.com
Home
Live Updates
Evogene : Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma : comparemela.com
Evogene : Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF...
Related Keywords
Israel ,
Washington ,
United States ,
Rehovot ,
Hamerkaz ,
American ,
Elran Haber ,
Rachel Pomerantz Gerber ,
Lavie Bio ,
Gal Markel ,
Yaron Eldad ,
Commission File Number ,
American Society Of Clinical Oncology Inc ,
Exchange Commission ,
Evogene Ltd ,
Nasdaq ,
Rabin Medical Center ,
Association For Clinical Oncology ,
Davidoff Cancer Center ,
Biomica Ltd ,
Securities Exchange ,
American Society Of Clinical Oncology ,
File Number ,
Feinstein Street ,
Park Rehovot ,
Foreign Private Issuer ,
Presents Positive Clinical Data Update ,
Ongoing Phase ,
Microbiome Based Therapeutic ,
Securities Exchange Act ,
Clinical Oncology ,
Scientific Advisory Board ,
American Society ,
Live Bacterial Product ,
Big Data ,
Artificial Intelligence ,
Looking Statements ,
Israel Hamas ,
Investor Relations ,
comparemela.com © 2020. All Rights Reserved.